These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7174795)

  • 1. Protective human hybridoma antibody to tetanus toxin.
    Gigliotti F; Insel RA
    J Clin Invest; 1982 Dec; 70(6):1306-9. PubMed ID: 7174795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of tetanus toxin by human monoclonal antibodies directed against tetanus toxin fragment C.
    Gustafsson B; Whitmore E; Tiru M
    Hybridoma; 1993 Dec; 12(6):699-708. PubMed ID: 8288271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of hybridomas secreting human monoclonal antibodies against tetanus toxin and hepatitis B virus surface antigen.
    Ichimori Y; Sasano K; Itoh H; Hitotsumachi S; Kimura Y; Kaneko K; Kida M; Tsukamoto K
    Biochem Biophys Res Commun; 1985 May; 129(1):26-33. PubMed ID: 2408619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single human monoclonal antibody that confers total protection from tetanus.
    Arunachalam B; Ghosh S; Talwar GP; Raghupathy R
    Hybridoma; 1992 Apr; 11(2):165-79. PubMed ID: 1376715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule.
    Ziegler-Heitbrock HW; Reiter C; Trenkmann J; Fütterer A; Riethmüller G
    Hybridoma; 1986; 5(1):21-31. PubMed ID: 2420699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective murine monoclonal antibodies to tetanus toxin.
    Shang HF; Liau MY; Chow MF; Jiang SY; Chen SC; Yeh MY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):199-209. PubMed ID: 3151481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducible production of protective human monoclonal antibodies by fusion of peripheral blood lymphocytes with a mouse myeloma cell line.
    Gigliotti F; Smith L; Insel RA
    J Infect Dis; 1984 Jan; 149(1):43-7. PubMed ID: 6607295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renewal of EBV-hybridoma method: efficient generation of recombinant fully human neutralizing IgG antibodies specific for tetanus toxin by use of tetroma cells.
    Ainai A; Kawase T; Ida A; Maeda Y; Ohba H; Ikeda Y; Sato H; Takahashi M; Chiba J
    Hum Antibodies; 2006; 15(4):139-54. PubMed ID: 17522436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences in the production of human monoclonal antibodies to tetanus toxoid.
    Boyd JE; Hastings I; Farzad Z; James K; McClelland DB
    Dev Biol Stand; 1984; 57():93-8. PubMed ID: 6526155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy with human monoclonal antibodies. Fragment A specificity of polyclonal and monoclonal antibodies is crucial for full protection against tetanus toxin.
    Lang AB; Cryz SJ; Schürch U; Ganss MT; Bruderer U
    J Immunol; 1993 Jul; 151(1):466-72. PubMed ID: 8326138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human hybridomas secreting antibody to tetanus toxoid.
    Larrick JW; Truitt KE; Raubitschek AA; Senyk G; Wang JC
    Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6376-80. PubMed ID: 6578513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies with a protective activity against tetanus toxin.
    Trabaud MA; Lery L; Desgranges C
    APMIS; 1989 Aug; 97(8):671-6. PubMed ID: 2475149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies as probes of tetanus toxin structure and function.
    Kenimer JG; Habig WH; Hardegree MC
    Infect Immun; 1983 Dec; 42(3):942-8. PubMed ID: 6642671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human monoclonal antibody specific for tetanus toxoid.
    Olsson L; Mazauric T; Vincent-Falquet JC; Armand J
    Dev Biol Stand; 1984; 57():87-91. PubMed ID: 6526153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and characterization of monoclonal antibodies to tetanus toxin.
    Sheppard AJ; Cussell D; Hughes M
    Infect Immun; 1984 Feb; 43(2):710-4. PubMed ID: 6198285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of mouse-human hybridoma as a useful fusion partner for the establishment of mouse-human-human hybridoma secreting anti-tetanus toxoid human monoclonal antibody of IgM or IgG class.
    Hirata Y; Sugawara I
    Microbiol Immunol; 1987; 31(3):231-45. PubMed ID: 3613992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralization of tetanus toxin by distinct monoclonal antibodies binding to multiple epitopes on the toxin molecule.
    Volk WA; Bizzini B; Snyder RM; Bernhard E; Wagner RR
    Infect Immun; 1984 Sep; 45(3):604-9. PubMed ID: 6205994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of toxin-neutralization by anti-tetanus human monoclonal antibodies directed against the three functional domains [A], [B] and [C] of the tetanus toxin molecule and a reliable method for evaluating the protective effects of monoclonal antibodies.
    Matsuda M; Kamei M; Sugimoto N; Ma Y; Hashizume S
    Eur J Epidemiol; 1992 Jan; 8(1):1-8. PubMed ID: 1572415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of neutralizing human monoclonal antibody directed to tetanus toxin in CHO cell.
    Chin J; Sohn Y; Lee SH; Park YI; Choi MJ
    Biologicals; 2003 Mar; 31(1):45-53. PubMed ID: 12623059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.